Comparative Acceptability and Perceived Clinical Utility of Monitoring Tools: A Nationwide Survey of Patients with Inflammatory Bowel Disease.

Date publication

août 2017

Journal

Inflammatory bowel diseases

Auteurs

Membres identifiés du Cancéropôle Est :
Pr PEYRIN-BIROULET Laurent

Tous les auteurs :
Buisson A, Gonzalez F, Poullenot F, Nancey S, Sollellis E, Fumery M, Pariente B, Flamant M, Trang-Poisson C, Bonnaud G, Mathieu S, Thevenin A, Duruy M, Filippi J, Lʼhopital F, Luneau F, Michalet V, Genès J, Achim A, Cruzille E, Bommelaer G, Laharie D, Peyrin-Biroulet L, Pereira B, Nachury M, Bouguen G,

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/28570431

Résumé

Objective control of intestinal inflammation during inflammatory bowel disease (IBD) is becoming the main driver for medical treatment. However, the monitoring tools-related burden remains poorly investigated. We aimed to evaluate their comparative acceptability and utility according to patients with IBD.

Mots clés

Adult, Biomarkers, analysis, Capsule Endoscopy, Colonoscopy, Female, Follow-Up Studies, Humans, Inflammatory Bowel Diseases, diagnosis, Male, Perception, Prognosis, Prospective Studies, Surveys and Questionnaires, Ultrasonography

Référence

Inflamm. Bowel Dis.. 2017 08;23(8):1425-1433